MAVENCLAD vs OCREVUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. MAVENCLAD and OCREVUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MAVENCLAD	OCREVUS
Rating	70/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CLADRIBINE	OCRELIZUMAB
Manufacturer	Emd Serono	Genentech Inc
Dosage forms	Tablet	Injectable
Drug class	Purine Antimetabolite	—
Boxed warning	Boxed warning	None
Treats	Hairy Cell Leukemia, Non-Hodgkin Lymphoma, Multiple Sclerosis	Multiple Sclerosis

mavenclad ocrevus

Rating

70/100

72/100

Pharmacy pays

—

Type

Active ingredient

CLADRIBINE

OCRELIZUMAB

Manufacturer

Emd Serono

Genentech Inc

Dosage forms

Tablet

Injectable

Drug class

Purine Antimetabolite

—

Boxed warning

None

Treats

Hairy Cell Leukemia, Non-Hodgkin Lymphoma, Multiple Sclerosis

Multiple Sclerosis

Frequently asked questions

Which is better-rated, Mavenclad or Ocrevus?

By our independent rating, Ocrevus scores higher — 3.6 vs 3.5 out of 5 for Mavenclad. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Mavenclad and Ocrevus?

Mavenclad contains Cladribine, while Ocrevus contains Ocrelizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.